The Seattle PI makes the economic case for federal support of R&D in an editorial today.

But what happens if the United States not only gives up every trade protection benefit, continues to suffer a loss of manufacturing and fritters away its research leadership in science, medicine and technology?
That’s a lose-lose proposition. And it ought to worry U.S. leaders a lot more than it has so far.

Read it all.